Susan J. Clark | |
---|---|
Education | Honours: Australian National University, 1978 PhD: University of Adelaide, 1982 |
Occupation | Scientist |
Title | Professor |
Website | https://www.garvan.org.au/people/researchers/susan-clark |
Susan J. Clark is an Australian biomedical researcher in epigenetics of development and cancer. She was elected a Fellow of the Australian Academy of Science in 2015,[1] and is a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellow and Research Director and Head of Genomics and Epigenetics Division at the Garvan Institute of Medical Research.[2] Clark developed the first method for bisulphite sequencing[3] for DNA methylation analysis and used it to establish that the methylation machinery of mammalian cells is capable of both maintenance and de novo methylation at CpNpG sites and showed is inheritable.[4] Clark's research has advanced understanding of the role of DNA methylation, non-coding RNA and microRNA in embryogenesis, reprogramming, stem cell development and cancer, and has led to the identification of epigenomic biomarkers in cancer.[5][6] Clark is a founding member of the International Human Epigenome Consortium (IHEC) and President of the Australian Epigenetics Alliance (AEpiA).[7]